Gilmore O’Neill
Vermogen: 859 163 $ op 31-05-2026
Vermogen: 859 163 $ op 31-05-2026
Gilmore ONeill bekleedt de functie van Chief Medical Officer & Executive Vice President bij Sarepta Therapeutics, Inc. Dr. ONeill is tevens lid van de raad van bestuur van de Massachusetts Biotechnology Council en Unity Biotechnology, Inc. en lid van de American Academy of Neurology. In zijn vorige loopbaan bekleedde hij de functie van Senior Vice President bij Biogen, Inc. Gilmore ONeill behaalde een doctoraal aan het University College Dublin en een doctoraal aan de Harvard University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-06-2026 | 248.313 ( 0,16% ) | 859 163 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| EDITAS MEDICINE, INC. | Algemeen Directeur | 01-06-2022 |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | - |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Directeur/Bestuurslid | 27-06-2025 |
| APTINYX | Directeur/Bestuurslid | 14-04-2023 |
| SAREPTA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 17-11-2021 |
| BIOGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2018 |
| APTINYX | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Aptinyx, Inc.
Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Unity Biotechnology, Inc.
Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau